France-based education technology developer Coorpacademy has raised $11m in a funding round that featured Debiopharm Investment, the corporate venturing division of drugs company Debiopharm, according to VentureBeat.
Venture capital firms Serena Capital and NextStageAM also contributed to the round. Debiopharm Investment had previously taken part in a €3.2m ($3.5m) funding round in 2014 that included NextStageAM.
Founded in 2013, Coorpacademy operates an e-learning platform that offers courses developed by corporate partners and third partners. The platform adds gamification and social dynamics to the courses in order to increase users’ drive to finish classes.
The money will support an expansion across Europe. Coorpacademy also hopes to develop additional content partnerships.
Jean-Marc Tassetto, co-founder of Coorpacademy, said: “The problem we had to attack is that corporate e-learning is boring. Our ambition is to bring back the pleasure of learning, and to encourage learners to develop their skills to their full potential.”